These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30101434)

  • 21. FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort.
    Vink FJ; Lissenberg-Witte BI; Meijer CJLM; Berkhof J; van Kemenade FJ; Siebers AG; Steenbergen RDM; Bleeker MCG; Heideman DAM
    Clin Microbiol Infect; 2021 Jan; 27(1):125.e1-125.e6. PubMed ID: 32222459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy.
    Hesselink AT; Heideman DA; Steenbergen RD; Gök M; van Kemenade FJ; Wilting SM; Berkhof J; Meijer CJ; Snijders PJ
    Int J Cancer; 2014 Aug; 135(4):880-6. PubMed ID: 24474183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.
    Hesselink AT; Heideman DA; Steenbergen RD; Coupé VM; Overmeer RM; Rijkaart D; Berkhof J; Meijer CJ; Snijders PJ
    Clin Cancer Res; 2011 Apr; 17(8):2459-65. PubMed ID: 21389098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer.
    De Strooper LM; van Zummeren M; Steenbergen RD; Bleeker MC; Hesselink AT; Wisman GB; Snijders PJ; Heideman DA; Meijer CJ
    J Clin Pathol; 2014 Dec; 67(12):1067-71. PubMed ID: 25281766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation analysis in urine fractions for optimal CIN3 and cervical cancer detection.
    van den Helder R; van Trommel NE; van Splunter AP; Lissenberg-Witte BI; Bleeker MCG; Steenbergen RDM
    Papillomavirus Res; 2020 Jun; 9():100193. PubMed ID: 32171935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.
    Boers A; Wang R; van Leeuwen RW; Klip HG; de Bock GH; Hollema H; van Criekinge W; de Meyer T; Denil S; van der Zee AGJ; Schuuring E; Wisman GBA
    Clin Epigenetics; 2016; 8():29. PubMed ID: 26962367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm.
    Chang CC; Huang RL; Liao YP; Su PH; Hsu YW; Wang HC; Tien CY; Yu MH; Lin YW; Lai HC
    BMC Cancer; 2015 May; 15():418. PubMed ID: 25985991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of hypermethylated genes in women with and without cervical neoplasia.
    Feng Q; Balasubramanian A; Hawes SE; Toure P; Sow PS; Dem A; Dembele B; Critchlow CW; Xi L; Lu H; McIntosh MW; Young AM; Kiviat NB
    J Natl Cancer Inst; 2005 Feb; 97(4):273-82. PubMed ID: 15713962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.
    Leeman A; Del Pino M; Marimon L; Torné A; Ordi J; Ter Harmsel B; Meijer CJLM; Jenkins D; Van Kemenade FJ; Quint WGV
    Int J Cancer; 2019 Jan; 144(1):160-168. PubMed ID: 30098013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of
    Wang Y; Chuan J; Zhu B; Zu Y; Zhang R; Tang L; Wen Y; Yang T; Chen K; Chen X; Bu Z; Zhuan S; Zhao Z; He Q; Li W; He J
    Epigenomics; 2023 Feb; 15(3):131-145. PubMed ID: 37020401
    [No Abstract]   [Full Text] [Related]  

  • 32. The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer.
    Barrett JE; Sundström K; Jones A; Evans I; Wang J; Herzog C; Dillner J; Widschwendter M
    Genome Med; 2022 Oct; 14(1):116. PubMed ID: 36258199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PAX1 methylation as a potential biomarker for cervical cancer screening.
    Kan YY; Liou YL; Wang HJ; Chen CY; Sung LC; Chang CF; Liao CI
    Int J Gynecol Cancer; 2014 Jun; 24(5):928-34. PubMed ID: 24844223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer.
    Hesselink AT; Berkhof J; Heideman DA; Bulkmans NW; van Tellingen JE; Meijer CJ; Snijders PJ
    Int J Cancer; 2009 Jan; 124(2):381-6. PubMed ID: 19003961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia.
    Lendvai Á; Johannes F; Grimm C; Eijsink JJ; Wardenaar R; Volders HH; Klip HG; Hollema H; Jansen RC; Schuuring E; Wisman GB; van der Zee AG
    Epigenetics; 2012 Nov; 7(11):1268-78. PubMed ID: 23018867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages.
    Schmitz M; Eichelkraut K; Schmidt D; Zeiser I; Hilal Z; Tettenborn Z; Hansel A; Ikenberg H
    BMC Cancer; 2018 Dec; 18(1):1197. PubMed ID: 30509219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA methylation analysis in liquid-based cytology for cervical cancer screening.
    Apostolidou S; Hadwin R; Burnell M; Jones A; Baff D; Pyndiah N; Mould T; Jacobs IJ; Beddows S; Kocjan G; Widschwendter M
    Int J Cancer; 2009 Dec; 125(12):2995-3002. PubMed ID: 19609949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study.
    Segondy M; Kelly H; Magooa MP; Djigma F; Ngou J; Gilham C; Omar T; Goumbri-Lompo O; Michelow P; Doutre S; Clavero O; Chikandiwa A; Sawadogo B; Didelot MN; Costes V; Méda N; Delany-Moretlwe S; Mayaud P
    Br J Cancer; 2016 Aug; 115(4):425-30. PubMed ID: 27434037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-time colorimetric detection of DNA methylation of the
    Huang J; Liou YL; Kang YN; Tan ZR; Peng MJ; Zhou HH
    Int J Nanomedicine; 2016; 11():5335-5347. PubMed ID: 27789946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.